Main

processing priority

3

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2023-10-05 20:48:45

expired found date

-

created at

2024-06-01 00:36:38

updated at

2026-03-03 20:56:45

Domain name statistics

length

12

crc

25739

tld

670

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

135099437

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

18461

mp size raw text

9163

mp inner links count

0

mp inner links status

20 (imported)

Open Graph

title

The Longevity Fund

description

The best longevity companies will be built this decade.

site name

author

updated

2025-12-13 15:02:18

raw text

The Longevity Fund Letter PORTFOLIO ABOUT NEXT ( age1 ) A LETTER FROM LAURA DEMING This is the decade in which we get drugs directly for longevity into the clinic Sept 2023 I started The Longevity Fund in 2011. Since then, we’ve funded some of the first companies in the space to IPO and get plausible drug candidates into patients (so far, all for age-related diseases, not longevity directly). We’re launching a new fund with a new name (excited to work with our new GP Alex Colville and team!), so I’ll summarize how I feel about the field on our old homepage. ‍ ‍ The longevity field will play out in 3 stages:  Pioneers (2013 - 2023) : companies started in this decade show you can make financial returns building a longevity company, and get reasonable drug candidates to patients for specific age-related diseases. ‍ Dominant players (2023 - 2050) : I think we’ll see a wave of the best founders the field has ever seen. They’ll be prepared with the right resources to ...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Nowotwory (78)

index version

2025110801

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

7242

text words

1441

text unique words

562

text lines

112

text sentences

85

text paragraphs

25

text words per sentence

16

text matched phrases

2

text matched dictionaries

3

RSS

rss path

rss status

3 (priority 3 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)

sitemap review version

2

sitemap urls count

3

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2023-12-23 20:21:49

sitemap process date

2025-05-04 05:20:39

sitemap first import date

-

sitemap last import date

2026-03-03 20:56:45